HBG2 and methemoglobinemia: After discontinuation of SMX/TMP and administration of a methylene blue dose of 1 mg/kg intravenously for the treatment of methemoglobinemia, the methemoglobin level decreased to 0.6%, and the fraction of inspired oxygen returned to the normal range.